A 2-phase screening process for patients with Wegener's granulomatosis: a pilot study.
A 2-phase screening process for patients with persistent upper respiratory tract manifestations for the detection of Wegener's granulomatosis (WG) was tested in 28 patients in this pilot study. One patient with WG was identified. A larger study is warranted.
Alarcón
Graciela S
GS
Division of Clinical Immunology and Rheumatology, Department of Medicine, 615 MEB, The University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Moreland
Larry W
LW
Sillers
Michael J
MJ
Morgan
Elliott
E
Carroll
William R
WR
D000328:Adult; D000368:Aged; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis; D003362:Cost-Benefit Analysis; D005240:Feasibility Studies; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics / Q000379:methods; D008875:Middle Aged; D010865:Pilot Projects
D019268:Antibodies, Antineutrophil Cytoplasmic